Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ — Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene…
Science & Climate
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 23, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company, today…
Zum Appoints Matthew Klein as VP of Software Sales
Klein will lead Zum’s software-only business as the company’s unified, AI-powered Zum CMX solution expands nationwide, reimagining student mobility for…
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026Emerging Discovery Programs Build…
New Smart Cities Technologies Improve Public Services Enhance Efficiency
New Smart Cities Technologies Improve Public Services Enhance Efficiency Cities around the world are rapidly adopting smart technologies to improve…